Annual Operating Profit
-$241.10 M
+$60.53 M+20.07%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual operating income is -$241.10 million, with the most recent change of +$60.53 million (+20.07%) on December 31, 2023.
- During the last 3 years, ARQT annual operating profit has fallen by -$104.46 million (-76.44%).
- ARQT annual operating profit is now -5771.92% below its all-time high of -$4.11 million, reached on December 31, 2017.
Performance
ARQT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$39.07 M
+$11.01 M+21.99%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly operating income is -$39.07 million, with the most recent change of +$11.01 million (+21.99%) on September 30, 2024.
- Over the past year, ARQT quarterly operating profit has dropped by -$2.16 million (-5.86%).
- ARQT quarterly operating profit is now -556.24% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$181.93 M
-$2.16 M-1.20%
September 30, 2024
Summary
- As of February 8, 2025, ARQT TTM operating income is -$181.93 million, with the most recent change of -$2.16 million (-1.20%) on September 30, 2024.
- Over the past year, ARQT TTM operating profit has increased by +$66.42 million (+26.74%).
- ARQT TTM operating profit is now -2956.17% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ARQT Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.1% | -5.9% | +26.7% |
| 3 y3 years | -76.4% | -5.9% | +26.7% |
| 5 y5 years | -1121.7% | -5.9% | +26.7% |
ARQT Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.7% | +20.1% | -23.5% | +62.7% | -1.2% | +42.5% |
| 5 y | 5-year | -459.0% | +20.1% | -200.7% | +62.7% | -321.8% | +42.5% |
| alltime | all time | -5771.9% | +20.1% | -556.2% | +62.7% | -2956.2% | +42.5% |
Arcutis Biotherapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$39.07 M(-22.0%) | -$181.93 M(+1.2%) |
| Jun 2024 | - | -$50.08 M(+58.4%) | -$179.77 M(-8.5%) |
| Mar 2024 | - | -$31.62 M(-48.3%) | -$196.46 M(-18.5%) |
| Dec 2023 | -$241.10 M(-20.1%) | -$61.17 M(+65.8%) | -$241.10 M(-2.9%) |
| Sep 2023 | - | -$36.90 M(-44.7%) | -$248.36 M(-21.5%) |
| Jun 2023 | - | -$66.76 M(-12.5%) | -$316.20 M(+0.3%) |
| Mar 2023 | - | -$76.27 M(+11.5%) | -$315.26 M(+4.5%) |
| Dec 2022 | -$301.63 M(+46.0%) | -$68.42 M(-34.7%) | -$301.63 M(-0.9%) |
| Sep 2022 | - | -$104.75 M(+59.1%) | -$304.49 M(+18.6%) |
| Jun 2022 | - | -$65.83 M(+5.1%) | -$256.82 M(+10.2%) |
| Mar 2022 | - | -$62.63 M(-12.1%) | -$233.07 M(+12.9%) |
| Dec 2021 | -$206.53 M | -$71.29 M(+24.9%) | -$206.53 M(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$57.08 M(+35.6%) | -$169.31 M(+12.5%) |
| Jun 2021 | - | -$42.08 M(+16.6%) | -$150.53 M(+4.5%) |
| Mar 2021 | - | -$36.09 M(+5.9%) | -$144.08 M(+5.4%) |
| Dec 2020 | -$136.65 M(+216.8%) | -$34.06 M(-11.1%) | -$136.65 M(+18.2%) |
| Sep 2020 | - | -$38.30 M(+7.5%) | -$115.58 M(+25.7%) |
| Jun 2020 | - | -$35.63 M(+24.3%) | -$91.92 M(+41.8%) |
| Mar 2020 | - | -$28.65 M(+120.5%) | -$64.83 M(+50.3%) |
| Dec 2019 | -$43.13 M(+118.6%) | -$12.99 M(-11.3%) | -$43.13 M(+19.5%) |
| Sep 2019 | - | -$14.65 M(+71.6%) | -$36.09 M(+68.3%) |
| Jun 2019 | - | -$8.54 M(+22.8%) | -$21.44 M(+66.2%) |
| Mar 2019 | - | -$6.95 M(+16.8%) | -$12.90 M(+116.8%) |
| Dec 2018 | -$19.73 M(+380.6%) | -$5.95 M | -$5.95 M |
| Dec 2017 | -$4.11 M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual operating income?
- What is the all time high annual operating profit for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual operating profit year-on-year change?
- What is Arcutis Biotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly operating profit year-on-year change?
- What is Arcutis Biotherapeutics TTM operating income?
- What is the all time high TTM operating profit for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM operating profit year-on-year change?
What is Arcutis Biotherapeutics annual operating income?
The current annual operating profit of ARQT is -$241.10 M
What is the all time high annual operating profit for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual operating income is -$4.11 M
What is Arcutis Biotherapeutics annual operating profit year-on-year change?
Over the past year, ARQT annual operating income has changed by +$60.53 M (+20.07%)
What is Arcutis Biotherapeutics quarterly operating income?
The current quarterly operating profit of ARQT is -$39.07 M
What is the all time high quarterly operating profit for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly operating income is -$5.95 M
What is Arcutis Biotherapeutics quarterly operating profit year-on-year change?
Over the past year, ARQT quarterly operating income has changed by -$2.16 M (-5.86%)
What is Arcutis Biotherapeutics TTM operating income?
The current TTM operating profit of ARQT is -$181.93 M
What is the all time high TTM operating profit for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM operating income is -$5.95 M
What is Arcutis Biotherapeutics TTM operating profit year-on-year change?
Over the past year, ARQT TTM operating income has changed by +$66.42 M (+26.74%)